A citation-based method for searching scientific literature

Harold E Lebovitz. Nat Rev Endocrinol 2010
Times Cited: 34







List of co-cited articles
127 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Pramlintide improved glycemic control and reduced weight in patients with type 2 diabetes using basal insulin.
Matthew Riddle, Juan Frias, Bei Zhang, Holly Maier, Carl Brown, Karen Lutz, Orville Kolterman. Diabetes Care 2007
72
5

The treatment of type 1 diabetes mellitus with agents approved for type 2 diabetes mellitus.
Kashif M Munir, Stephen N Davis. Expert Opin Pharmacother 2015
11
18

Role of glucagon-like peptide-1 analogue versus amylin as an adjuvant therapy in type 1 diabetes in a closed loop setting with ePID algorithm.
Venkat Sasidhar Renukuntla, Neesha Ramchandani, Jeniece Trast, Martin Cantwell, Rubina A Heptulla. J Diabetes Sci Technol 2014
31
6

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
5

High prevalence of the polycystic ovary syndrome and hirsutism in women with type 1 diabetes mellitus.
H F Escobar-Morreale, B Roldán, R Barrio, M Alonso, J Sancho, H de la Calle, R García-Robles. J Clin Endocrinol Metab 2000
78
5

Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group.
Bart C J M Fauser, Basil C Tarlatzis, Robert W Rebar, Richard S Legro, Adam H Balen, Roger Lobo, Enrico Carmina, Jeffrey Chang, Bulent O Yildiz, Joop S E Laven,[...]. Fertil Steril 2012
826
5

Diagnostic criteria for polycystic ovary syndrome and ovarian morphology in women with type 1 diabetes mellitus.
Ethel Codner, Nestor Soto, Patricia Lopez, León Trejo, Alejandra Avila, Francisca C Eyzaguirre, Germán Iniguez, Fernando Cassorla. J Clin Endocrinol Metab 2006
72
5

SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice.
Volker Vallon, Maria Gerasimova, Michael A Rose, Takahiro Masuda, Joseph Satriano, Eric Mayoux, Hermann Koepsell, Scott C Thomson, Timo Rieg. Am J Physiol Renal Physiol 2014
252
5

Treatment of diabetes in children.
Yi-Qing Gao, Min Gao, Ying Xue. Exp Ther Med 2016
5
40

Effect of adjunct metformin treatment on levels of plasma lipids in patients with type 1 diabetes.
S S Lund, L Tarnow, A S Astrup, P Hovind, P K Jacobsen, A C Alibegovic, I Parving, L Pietraszek, M Frandsen, P Rossing,[...]. Diabetes Obes Metab 2009
29
6

2
100



A model of glucose-insulin-pramlintide pharmacokinetics and pharmacodynamics in type I diabetes.
Charrise M Ramkissoon, Brian Aufderheide, B Wayne Bequette, Cesar C Palerm. J Diabetes Sci Technol 2014
4
50

Addition of exenatide or sitagliptin to insulin in new onset type 1 diabetes: a randomized, open label study.
K V S Hari Kumar, Altamash Shaikh, Pitambar Prusty. Diabetes Res Clin Pract 2013
61
5

Effect of pramlintide on prandial glycemic excursions during closed-loop control in adolescents and young adults with type 1 diabetes.
Stuart A Weinzimer, Jennifer L Sherr, Eda Cengiz, Grace Kim, Jessica L Ruiz, Lori Carria, Gayane Voskanyan, Anirban Roy, William V Tamborlane. Diabetes Care 2012
92
5


Fixed ratio dosing of pramlintide with regular insulin before a standard meal in patients with type 1 diabetes.
M C Riddle, K C J Yuen, T W de Bruin, K Herrmann, J Xu, P Öhman, O G Kolterman. Diabetes Obes Metab 2015
16
12

Effect of Metformin Added to Insulin on Glycemic Control Among Overweight/Obese Adolescents With Type 1 Diabetes: A Randomized Clinical Trial.
Ingrid M Libman, Kellee M Miller, Linda A DiMeglio, Kathleen E Bethin, Michelle L Katz, Avni Shah, Jill H Simmons, Michael J Haller, Sripriya Raman, William V Tamborlane,[...]. JAMA 2015
99
5

The effect of metformin in overweight patients with type 1 diabetes and poor metabolic control.
Iben Brock Jacobsen, Jan Erik Henriksen, Henning Beck-Nielsen. Basic Clin Pharmacol Toxicol 2009
35
5

Empagliflozin as adjunct to insulin in patients with type 1 diabetes: a 4-week, randomized, placebo-controlled trial (EASE-1).
T R Pieber, S Famulla, J Eilbracht, J Cescutti, N Soleymanlou, O E Johansen, H J Woerle, U C Broedl, S Kaspers. Diabetes Obes Metab 2015
108
5

A pilot trial of pramlintide home usage in adolescents with type 1 diabetes.
Christopher M Kishiyama, Patricia L Burdick, Erin C Cobry, Victoria L Gage, Laurel H Messer, Kim McFann, H Peter Chase. Pediatrics 2009
12
16

Mechanisms of glucagon degradation at alkaline pH.
Nicholas Caputo, Jessica R Castle, Colin P Bergstrom, Julie M Carroll, Parkash A Bakhtiani, Melanie A Jackson, Charles T Roberts, Larry L David, W Kenneth Ward. Peptides 2013
27
7

Effect of Pramlintide on Postprandial Glucose Fluxes in Type 1 Diabetes.
Ling Hinshaw, Michele Schiavon, Vikash Dadlani, Ashwini Mallad, Chiara Dalla Man, Adil Bharucha, Rita Basu, Jennifer R Geske, Rickey E Carter, Claudio Cobelli,[...]. J Clin Endocrinol Metab 2016
20
10

Current use of metformin in addition to insulin in pediatric patients with type 1 diabetes mellitus: an analysis based on a large diabetes registry in Germany and Austria.
Katja Konrad, Nicolin Datz, Ilse Engelsberger, Jürgen Grulich-Henn, Thomas Hoertenhuber, Burkhild Knauth, Thomas Meissner, Susanna Wiegand, Joachim Woelfle, Reinhard W Holl. Pediatr Diabetes 2015
19
10

Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial.
John R Petrie, Nishi Chaturvedi, Ian Ford, Martijn C G J Brouwers, Nicola Greenlaw, Therese Tillin, Irene Hramiak, Alun D Hughes, Alicia J Jenkins, Barbara E K Klein,[...]. Lancet Diabetes Endocrinol 2017
146
5

Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial.
Jolien de Jager, Adriaan Kooy, Philippe Lehert, Michiel G Wulffelé, Jan van der Kolk, Daniël Bets, Joop Verburg, Ab J M Donker, Coen D A Stehouwer. BMJ 2010
247
2

Relationship between surgeon volume and adverse outcomes after RYGB in Longitudinal Assessment of Bariatric Surgery (LABS) study.
Mark D Smith, Emma Patterson, Abdus S Wahed, Steven H Belle, Marc Bessler, Anita P Courcoulas, David Flum, Valerie Halpin, James E Mitchell, Alfons Pomp,[...]. Surg Obes Relat Dis 2010
43
2

Why don't diabetes patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensification.
Julie A Schmittdiel, Connie S Uratsu, Andrew J Karter, Michele Heisler, Usha Subramanian, Carol M Mangione, Joe V Selby. J Gen Intern Med 2008
174
2

Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the LEAD (liraglutide effect and action in diabetes)-2 study.
Michael Nauck, Anders Frid, Kjeld Hermansen, Nalini S Shah, Tsvetalina Tankova, Ismail H Mitha, Milan Zdravkovic, Maria Düring, David R Matthews. Diabetes Care 2009
787
2

Gastric banding or bypass? A systematic review comparing the two most popular bariatric procedures.
Jeffrey A Tice, Leah Karliner, Judith Walsh, Amy J Petersen, Mitchell D Feldman. Am J Med 2008
303
2

Impact of gastric bypass operation on survival: a population-based analysis.
David R Flum, E Patchen Dellinger. J Am Coll Surg 2004
356
2

Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial.
Alan Garber, Robert Henry, Robert Ratner, Pedro A Garcia-Hernandez, Hiromi Rodriguez-Pattzi, Israel Olvera-Alvarez, Paula M Hale, Milan Zdravkovic, Bruce Bode. Lancet 2009
768
2

Correlates of insulin injection omission.
Mark Peyrot, Richard R Rubin, Davida F Kruger, Luther B Travis. Diabetes Care 2010
254
2

Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial.
Matthew C Riddle, Walter T Ambrosius, David J Brillon, John B Buse, Robert P Byington, Robert M Cohen, David C Goff, Saul Malozowski, Karen L Margolis, Jeffrey L Probstfield,[...]. Diabetes Care 2010
307
2

Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action.
Francesco Rubino, Philip R Schauer, Lee M Kaplan, David E Cummings. Annu Rev Med 2010
260
2

Diabetes mellitus: subclinical cardiovascular disease and risk of incident cardiovascular disease and all-cause mortality.
L H Kuller, P Velentgas, J Barzilay, N J Beauchamp, D H O'Leary, P J Savage. Arterioscler Thromb Vasc Biol 2000
125
2


Effects of intensive glucose lowering in type 2 diabetes.
Hertzel C Gerstein, Michael E Miller, Robert P Byington, David C Goff, J Thomas Bigger, John B Buse, William C Cushman, Saul Genuth, Faramarz Ismail-Beigi, Richard H Grimm,[...]. N Engl J Med 2008
2


Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients.
Nicolas V Christou, John S Sampalis, Moishe Liberman, Didier Look, Stephane Auger, Alexander P H McLean, Lloyd D MacLean. Ann Surg 2004
850
2


Treatment of insulin resistance in diabetes mellitus.
Harold E Lebovitz, Mary Ann Banerji. Eur J Pharmacol 2004
56
2



Diabetes and cancer.
Paolo Vigneri, Francesco Frasca, Laura Sciacca, Giuseppe Pandini, Riccardo Vigneri. Endocr Relat Cancer 2009
655
2

Effect of a multifactorial intervention on mortality in type 2 diabetes.
Peter Gaede, Henrik Lund-Andersen, Hans-Henrik Parving, Oluf Pedersen. N Engl J Med 2008
2

Bariatric surgery: risks and rewards.
Walter J Pories. J Clin Endocrinol Metab 2008
198
2



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.